<!DOCTYPE html><html><head><title> Pacifica Code Section 58-38a-S204 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b>58-38a-204.&nbsp;
          </b><b>Guidelines for scheduling or listing drugs.</b>
<br>
<a id="58-38a-204(1)" name="58-38a-204(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%"><a id="58-38a-204(1)(a)" name="58-38a-204(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The committee shall recommend placement of a substance in Schedule I if it finds:<a id="58-38a-204(1)(a)(i)" name="58-38a-204(1)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
that the substance has high potential for abuse; and</td>
</tr>
</tbody></table>
<a id="58-38a-204(1)(a)(ii)" name="58-38a-204(1)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
that an accepted standard has not been established for safe use in treatment for medical purposes.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(1)(b)" name="58-38a-204(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
The committee may recommend placement of a substance in Schedule I under Section <a href="../../Title58/Chapter37/58-37-S4.html?v=C58-37-S4_2015051220150512">58-37-4</a> if it finds that the substance is classified as a controlled substance in Schedule I under federal law.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(2)" name="58-38a-204(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%"><a id="58-38a-204(2)(a)" name="58-38a-204(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The committee shall recommend placement of a substance in Schedule II if it finds that:<a id="58-38a-204(2)(a)(i)" name="58-38a-204(2)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the substance has high potential for abuse;</td>
</tr>
</tbody></table>
<a id="58-38a-204(2)(a)(ii)" name="58-38a-204(2)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the substance has a currently accepted medical use in treatment in the United States, or a currently accepted medical use subject to severe restrictions; and</td>
</tr>
</tbody></table>
<a id="58-38a-204(2)(a)(iii)" name="58-38a-204(2)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
the abuse of the substance may lead to severe psychological or physiological dependence.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(2)(b)" name="58-38a-204(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
The committee may recommend placement of a substance in Schedule II if it finds that the substance is classified as a controlled substance in Schedule II under federal law.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(3)" name="58-38a-204(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%"><a id="58-38a-204(3)(a)" name="58-38a-204(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The committee shall recommend placement of a substance in Schedule III if it finds that:<a id="58-38a-204(3)(a)(i)" name="58-38a-204(3)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the substance has a potential for abuse that is less than the potential for substances listed in Schedules I and II;</td>
</tr>
</tbody></table>
<a id="58-38a-204(3)(a)(ii)" name="58-38a-204(3)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the substance has a currently accepted medical use in treatment in the United States; and</td>
</tr>
</tbody></table>
<a id="58-38a-204(3)(a)(iii)" name="58-38a-204(3)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
abuse of the substance may lead to moderate or low physiological dependence or high psychological dependence.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(3)(b)" name="58-38a-204(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
The committee may recommend placement of a substance in Schedule III if it finds that the substance is classified as a controlled substance in Schedule III under federal law.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(4)" name="58-38a-204(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%"><a id="58-38a-204(4)(a)" name="58-38a-204(4)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The committee shall recommend placement of a substance in Schedule IV if it finds that:<a id="58-38a-204(4)(a)(i)" name="58-38a-204(4)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the substance has a low potential for abuse relative to substances in Schedule III;</td>
</tr>
</tbody></table>
<a id="58-38a-204(4)(a)(ii)" name="58-38a-204(4)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the substance has currently accepted medical use in treatment in the United States; and</td>
</tr>
</tbody></table>
<a id="58-38a-204(4)(a)(iii)" name="58-38a-204(4)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
abuse of the substance may lead to limited physiological dependence or psychological dependence relative to the substances in Schedule III.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(4)(b)" name="58-38a-204(4)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
The committee may recommend placement of a substance in Schedule IV if it finds that the substance is classified as a controlled substance in Schedule IV under federal law.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(5)" name="58-38a-204(5)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(5)</td><td style="width:99%"><a id="58-38a-204(5)(a)" name="58-38a-204(5)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
The committee shall recommend placement of a substance in Schedule V if it finds that:<a id="58-38a-204(5)(a)(i)" name="58-38a-204(5)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the substance has low potential for abuse relative to the controlled substances listed in Schedule IV;</td>
</tr>
</tbody></table>
<a id="58-38a-204(5)(a)(ii)" name="58-38a-204(5)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the substance has currently accepted medical use in treatment in the United States; and</td>
</tr>
</tbody></table>
<a id="58-38a-204(5)(a)(iii)" name="58-38a-204(5)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
the substance has limited physiological dependence or psychological dependence liability relative to the controlled substances listed in Schedule IV.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(5)(b)" name="58-38a-204(5)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
The committee may recommend placement of a substance in Schedule V under this chapter if it finds that the substance is classified as a controlled substance in Schedule V under federal law.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="58-38a-204(6)" name="58-38a-204(6)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(6)</td><td style="width:99%">
The committee may recommend placement of a substance on a controlled substance list if it finds that the substance has a potential for abuse and that an accepted standard has not been established for safe use in treatment for medical purposes.</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=12&amp;sess=2011GS">12</a>, 2011 General Session<br>
</body></html>